Millions of Americans take antidepressants every day. Millions more reach for diet sodas, sugar-free gum, or low-calorie snacks sweetened with natural and artificial sweeteners. What happens when both of those things meet in the gut at the same time? According to a new study, the answer may be more tangled than previously thought.
Researchers tested 39 commercially available sweeteners, the kind found in everything from soft drinks and candy to cereal and baby formula, against 25 gut bacterial strains and species to see how they interact. Reporting in Molecular Systems Biology, the team found that three-quarters of the sweeteners directly affected the growth of at least one bacterial strain. A bigger surprise came when sweeteners were combined with other commonly ingested compounds, including the widely prescribed antidepressant duloxetine. Those combinations produced more than 100 previously unreported interactions, some of which appeared to harm bacteria closely linked to human health.
Conducted entirely in a laboratory setting, the study does not prove that the same effects occur in a living human body. But the scale of the screening and the depth of the follow-up analysis make it one of the most thorough looks yet at what low-calorie sweeteners might be doing to the microscopic community living in the human digestive system.
How a Sweetener and an Antidepressant Gang Up on Gut Bacteria
Of all the findings in the study, one combination stood out. Isosteviol, a compound derived from the stevia plant and used as a sweetener ingredient, combined with duloxetine, the antidepressant sold under the brand name Cymbalta, to suppress two types of bacteria that scientists associate with a healthy gut, hitting one of them especially hard.
One of those bacteria, Roseburia intestinalis, has been linked to blood sugar regulation and protection against intestinal inflammation. The other, Parabacteroides merdae, is a common gut resident tied to a healthy microbial community. When isosteviol and duloxetine were present together, their combined suppressive effect on these bacteria was greater than what either compound caused on its own.
Duloxetine is no niche medication. In 2022 and 2023, it ranked as the 31st-most-prescribed drug in the United States, with more than 18 million prescriptions filled and more than 4 million patients taking it, according to data cited in the study. Given how widely stevia-derived sweeteners are used in food products, many people may routinely consume both.
How Scientists Tested 39 Sweeteners Against Gut Bacteria
Based at the MRC Toxicology Unit at the University of Cambridge and the European Molecular Biology Laboratory in Heidelberg, Germany, the research team built their experiment around 25 gut bacterial strains and species chosen to represent the broad range of bacteria found in a healthy human gut: friendly probiotic species, common residents, and some opportunistic troublemakers.
Against these bacteria, the team screened all 39 sweeteners they could obtain in pure form, covering both natural options like stevia compounds and monk fruit extract and synthetic ones like saccharin, aspartame, and sucralose. Every sweetener was tested individually against every bacterial strain, producing 975 unique pairings. Interactions counted as real only if they held up across multiple independent experiments and multiple concentrations, a strict standard that filtered out false positives.
For the combination testing, the researchers screened the same 39 sweeteners alongside four compounds commonly consumed with sweeteners: advantame (another sweetener increasingly used in processed foods), caffeine, vanillin (a flavor compound found in everything from cakes to baby formula), and duloxetine. That expanded the analysis to 3,900 three-way interactions between sweeteners, bacteria, and the added compounds.
In total, the combination screen identified 102 significant interactions involving nine gut bacterial species. Most of them, 68 out of 102, were cases where one compound softened the impact of the other. But 34 were cases where the combination hit harder than either compound alone. The strongest of all the compounds involved is isosteviol, followed by duloxetine, acting on Roseburia intestinalis.
Beyond Slowed Growth: Effects on Gut Bacteria and Human Cells
Finding that a sweetener and an antidepressant can together suppress specific gut bacteria would be notable on its own. The researchers went further, building a miniature artificial gut community comprising all 25 bacterial strains and exposing it to the isosteviol-duloxetine combination over several growth cycles to observe how the community changed under pressure.
Combined treatment caused a significant drop in overall species diversity. Of the 25 bacteria, 24 grew less in isolation after exposure to both compounds together.
To understand what was happening at a molecular level, the team analyzed changes in proteins made by Roseburia intestinalis and Parabacteroides merdae after exposure. The compounds appeared to interfere with the bacteria’s ability to manage what moves in and out of the cell, specifically disrupting proteins that carry small molecules across the outer membrane. A separate genetic analysis using a library of bacterial mutants identified the same membrane transport proteins as key determinants of bacterial survival of the isosteviol-duloxetine combination.
One of the more arresting downstream results involved the spent liquid from the bacterial community, essentially the chemical output that bacteria produce and release. Applied to human cells in a dish, fluid from communities treated with the isosteviol-duloxetine combination was significantly more toxic to HeLa cells than fluid from untreated communities. Researchers ruled out the compounds themselves as the direct cause; the altered bacterial output appeared to drive the effect.
When Caco-2 cells, a human cell line modeled on the lining of the colon, were exposed to the same bacterial fluid, secretion of two immune signaling proteins, interleukin-6 and interleukin-8, fell by more than 75% compared with fluid from untreated communities. These proteins are part of the gut’s immune defense. Their suppression could, depending on the context, indicate a weakened ability to fight off pathogens, though the researchers note that the significance would depend on a person’s individual health.
Bacteria exposed to the combination also produced different amounts of butyric acid, a compound tied to anti-inflammatory effects, improved insulin sensitivity, and protection against diet-related obesity, and one that gut cells burn for energy. In Roseburia intestinalis, butyric acid dropped by more than 25% after co-exposure. These are the kinds of bacterial outputs that researchers link to broader human health.
Source : https://studyfinds.com/could-common-antidepressant-and-sweetener-combo-quietly-fight-gut-bacteria/
